Navigation Links
SARS: India's drugs in demand,,

In a report from the Indian capital, the SARS virus has increased demand for macrolides, resulting in severely affected countries like China approaching the Indian pharmaceutical companies for additional supplies. Macrolides are a family of antibiotics that treat a wide range of bacterial infections. While doctors are still battling with the exact cure for SARS, macrolides, commonly used for treating lower respiratory tract infections, seems to have emerged as a preferred drug// in treating SARS.

Indian pharmaceutical companies have reported that order inquiries have gone up by four to five times from China and Southeast Asia, which forms the epicenter of the epidemic. China is turning to India at this stage as it traditionally meets some of its macrolide requirements.

While medical practitioners are still struggling to find the cure for the killer disease, the macrolides, widely used for treating pneumonia, are the favored drug prescribed by medical pfsractitioners at present. Macrolides include drugs such as erythromycin, azithromycin, clarithromycin and roxithromycin. They are particularly useful in the treatment of lower respiratory track infections.
'"/>




Page: 1

Related medicine news :

1. Indias anti-AIDS drug market engaged in price war
2. Indias Hospitals Among The Best, Says Renuka Chowdhury
3. Indias vaccination project gets a boost
4. WHO Commends Indias Bird Flu Response
5. Minister Of State For Industry Urges Corporate Sectors To Help Indias Disabled Population
6. Indias Economic Boom Pack To Waste Children Life
7. Indias Northeast Students to Get Satellite-based Education Soon
8. Norway Grants $80 mn to Indias Health Mission
9. Pakistani Child is Indias Youngest Liver Transplant Recipient
10. Avian flu-free Status to Boost Indias Poultry Exports
11. Britains Support for Indias Health Programme
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: SARS India drugs demand

(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... July is National UV Awareness Month, and ... Washington, DC shares tips on how to protect skin from the sun, as well as ... skin cancer, and is one of the most common skin conditions in America. Many people ...
(Date:7/29/2015)... ... July 29, 2015 , ... It is unique for a ... a tremendous model of care. One that is very hands on and resident oriented, ... of Monarch Landing. “She’s bringing great passion and energy, as well as a strong ...
(Date:7/29/2015)... ... July 29, 2015 , ... Several years ago, in order to be ... Little City took a proactive stance and began planning the Children’s Village consisting of ... valuable support to building the third home. , “We are very pleased to have ...
(Date:7/29/2015)... ... July 29, 2015 , ... Zofran lawsuits around the nation ... Litigation (JPML), according to court documents.* Attorneys handling Zofran lawsuits provide ... Defects Lawsuit Center. , GlaxoSmithKline, the global pharmaceutical conglomerate and defendant in national ...
(Date:7/29/2015)... ... ... " mybody ” was featured on NewsWatch as part of its monthly Biz Report, ... their industry. Andrew Tropeano, the host of NewsWatch and business expert, conducted the business ... strengthen the skin’s defense system from the inside out. , According to Statista, the ...
Breaking Medicine News(10 mins):Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3Health News:New Medical Director Readies To Take Reins at Monarch Landing 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 3Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2
... a survey done by the Canadian Institute of Medicine it was ... calories//. ,They lack a balanced diet which in turn ... to 50 derived their daily calories from fat which is the ... interviewed more than 35,000 people and questioned them about their food ...
... new campaign has been launched yesterday for the betterment ... rheumatoid arthritis in the midst of a growing concern ... treatment in Scotland. ,Charities, the National Rheumatoid ... health authorities to ensure that the funds available to ...
... conducted in UK has uncovered that children in families with ... to die than children from more advantaged backgrounds//. ... Hygiene & Tropical Medicine and Camden Primary Care Trust, reveals ... employment have failed to benefit from the fall in child ...
... spurious drugs and arrested one person in this connection for ... ,Acting on a tip-off, a police team raided ... medicines. The owner of the store was arrested, officials said., ... genuine versions would have been worth Rs 15 lakh, were ...
... University of Oxford have claimed that their study that ... be very widespread among young children//. ,Bordatella ... known as ‘Pertussis’. This bacterial infection was once a ... year, before the vaccine was introduced in the 1950s. ...
... persons died of gastroenteritis and diarrhoea and 55 others were ... sub-division //. ,The deaths of an eight-year-old boy ... amidst apprehensions of an outbreak of cholera. Medical teams were ... said 4-5 teams of doctors have been rushed to the ...
Cached Medicine News:Health News:Campaign For Arthritis Awareness Launched In Scotland 2Health News:Children of Unemployed Parents at 13 per cent increased risk of death 2Health News:Researchers Warn That Whooping Cough Is Still Very Prevalent 2Health News:Researchers Warn That Whooping Cough Is Still Very Prevalent 3
(Date:7/29/2015)... and PITTSBURGH , July 29, 2015 ... that it received regulatory clearance from the European Commission ... proposed acquisition of Perrigo Company plc (NYSE: PRGO ... Robert J. Coury commented, "Today marks yet another ... of Perrigo and serves as further affirmation of the ...
(Date:7/29/2015)... NEW YORK and ... -- CMC Biologics, a global leader in clinical and ... Corporation (River Vision), a private company focused on ... an agreement for the process transfer and cGMP ... antibody targeting insulin-like growth factor 1 that is ...
(Date:7/28/2015)... , July 28, 2015 Amgen (NASDAQ: ... declared a $0.79 per share dividend for the third ... Sept. 8, 2015, to all stockholders of record as ... About Amgen Amgen is committed to ... serious illnesses by discovering, developing, manufacturing and delivering innovative ...
Breaking Medicine Technology:Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 2Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 3Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 5Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 6Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 7Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 8Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 9CMC Biologics and River Vision Development Corporation Announce Manufacturing Agreement for RV001, a Monoclonal Antibody to Treat Grave's Orbitopathy 2CMC Biologics and River Vision Development Corporation Announce Manufacturing Agreement for RV001, a Monoclonal Antibody to Treat Grave's Orbitopathy 3Amgen Announces 2015 Third Quarter Dividend 2Amgen Announces 2015 Third Quarter Dividend 3
... SHELTON, Conn., Aug. 5 /PRNewswire/-- Cara Therapeutics, ... clinical trial for its second-generation,peripherally acting kappa ... of acute and chronic pain. The drug ... and resulted in plasma levels of,CR845 expected ...
... Effects of Eligen(R) Delivery Technology and ... Women, CEDAR KNOLLS, N.J., Aug. 5 ... that Novartis Pharma AG,has finished recruitment for a ... of Salmon Calcitonin and Emisphere,s proprietary,Eligen(R) Technology in ...
Cached Medicine Technology:Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845 2Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment 2
Kerrison (Spurling) Laminectomy Rongeur. 15 cm - 6, thick footplate, large handle, 90 up-cutting, 2 mm wide....
Spurling-Kerrison (Colclough) Laminectomie Rongeur. 15 cm - 6, thick footplate, large handle, 40 up-cutting, jaws 3 mm wide....
Micro-Kerrison Laminectomie Rongeur and Stella Punch, golden springs, with ejector. 18 cm - 7 1/8, very delicate, narrow footplate, small handle, 40 up-cutting, jaws 2 mm wide....
Kerrison (Micro) Laminectomy rongeur with ejector. 18 cm - 7 1/8, thick footplate, small handle, very delicate, 40 up-cutting, jaws 2 mm wide....
Medicine Products: